Gemina Laboratories Ltd. announced that it has appointed the global investment bank Stifel as its sole and exclusive financial advisor to the Company, as it considers strategic licensing and partnership opportunities for its breakthrough diagnostics technology.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.83 USD | -0.83% | -0.44% | +19.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.78% | 8.49B | |
+5.69% | 160B | |
+17.57% | 154B | |
+8.58% | 137B | |
+23.25% | 121B | |
-6.82% | 36.51B | |
+12.74% | 26.05B | |
-4.64% | 21.41B | |
+17.49% | 19.98B | |
+38.54% | 16.99B |
- Stock Market
- Equities
- SF Stock
- News Stifel Financial Corp.
- Gemina Laboratories Ltd. Appoints Stifel as Financial Advisor